华鲁网群
综合内网 English
投资者关系
信息透明,信任同行
投资者关系
30
2025-06
Overseas Regulatory Announcement-Announcement on Ibuprofen Arginine Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs
30
2025-06
海外監管公告-關於獲得精氨酸布洛芬化學原料藥上市申請批准通知書的公告
30
2025-06
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
30
2025-06
海外監管公告-關於獲得《藥品補充申請批准通知書》等相關情況的公告
27
2025-06
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
27
2025-06
海外監管公告-關於獲得《藥品補充申請批准通知書》等相關情況的公告
19
2025-06
Overseas Regulatory Announcement- Announcement on the Completion of Enrollment of the First Patient in China for Phase II Clinical Trials of OAB-14 Dry Suspension
19
2025-06
海外監管公告-關於OAB-14幹混懸劑完成Ⅱ期臨床中國首例患者入組的公告
13
2025-06
Articles of Association
13
2025-06
公司章程
总条数: 81